Progestogen-only pill

Progestogen-only pill
Progestogen-only pill
Background
Type	Hormonal
First use	1968
Failure rates (first year)
Perfect use	0.3%
Typical use	9%
Usage
Duration effect	1 day
Reversibility	Yes
User reminders	Taken within same 3-hour window each day
Clinic review	6 months
Advantages and disadvantages
STI protection	No
Weight	No proven effect
Period disadvantages	Light spotting may be irregular
Period advantages	Often lighter and less painful
Medical notes
	Unaffected by being on most (but not all) antibiotics. May be used, unlike COCPs, in patients with hypertension and history of migraines. Affected by some anti-epileptics.

Progestogen-only pills (POPs), colloquially known as "mini pills", are a type of oral contraceptive that contain synthetic progestogens (progestins) and do not contain estrogens.^[4] They are primarily used for the prevention of undesired pregnancy, although additional medical uses also exist.^[5]

Progestogen-only pills differ from combined oral contraceptive pills (COCPs), which instead consist of a combination of synthetic estrogens and progestin hormones.^[6]

^ Cite error: The named reference Gelijns1991 was invoked but never defined (see the help page).
^ Cite error: The named reference Bennett1974 was invoked but never defined (see the help page).
^ ^a ^b Trussell, James (2011). "Contraceptive efficacy". In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2013-11-12 at the Wayback Machine
^ Dhont, Marc (December 2010). "History of oral contraception". The European Journal of Contraception & Reproductive Health Care. 15 (Suppl 2): S12–18. doi:10.3109/13625187.2010.513071. ISSN 1473-0782. PMID 21091163.
^ "Progestin-Only Hormonal Birth Control: Pill and Injection". www.acog.org. Retrieved 2023-11-14.
^ Whitaker, Amy K.; Gilliam, Melissa (June 2008). "Contraceptive care for adolescents". Clinical Obstetrics and Gynecology. 51 (2): 268–280. doi:10.1097/GRF.0b013e31816d713e. ISSN 1532-5520. PMID 18463458. S2CID 13450620.

[Gelijns1991-1] Cite error: The named reference Gelijns1991 was invoked but never defined (see the help page).

[Bennett1974-2] Cite error: The named reference Bennett1974 was invoked but never defined (see the help page).

[Trussell_2011-3] Trussell, James (2011). "Contraceptive efficacy". In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2013-11-12 at the Wayback Machine

[4] Dhont, Marc (December 2010). "History of oral contraception". The European Journal of Contraception & Reproductive Health Care. 15 (Suppl 2): S12–18. doi:10.3109/13625187.2010.513071. ISSN 1473-0782. PMID 21091163.

[5] "Progestin-Only Hormonal Birth Control: Pill and Injection". www.acog.org. Retrieved 2023-11-14.

[6] Whitaker, Amy K.; Gilliam, Melissa (June 2008). "Contraceptive care for adolescents". Clinical Obstetrics and Gynecology. 51 (2): 268–280. doi:10.1097/GRF.0b013e31816d713e. ISSN 1532-5520. PMID 18463458. S2CID 13450620.

[1]

[2]

[3]

[4]

[5]

[6]